Sema4 Achieves HITRUST CSF Certification STAMFORD, Conn., April 06, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that its health intelligence platform,...

BioIntelliSense and Renown Health Announce Strategic Collaboration to Provide Continuous Medical Grade Patient Monitoring from In-Hospital to Home DENVER , CO and RENO, NV, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, has entered into a strategic collaboration with Renown...